Estudio de pacientes pediátricos con fenotipo clínico y bioquímico de síndrome de déficit de transportador de glucosa cerebral (GLUT-1)

De Vivo, 1991, Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay, N Engl J Med, 325, 703, 10.1056/NEJM199109053251006 Pascual, 2015, Glucose transporter type I deficiency (G1D) at 25 (1990-2015): Presumptions facts and the lives of persons with this rare disease, Pediatr Neurol., 53, 379, 10.1016/j.pediatrneurol.2015.08.001 Klepper, 2012, GLUT1 deficiency syndrome in clinical practice, Epilepsy Res., 100, 272, 10.1016/j.eplepsyres.2011.02.007 Leen, 2010, Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder, Brain., 133, 655, 10.1093/brain/awp336 Hao, 2017, Clinical aspects of glucose transporter type 1 deficiency: information from a global registry, JAMA Neurol., 74, 727, 10.1001/jamaneurol.2017.0298 Leen, 2013, Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome. A systematic review, JAMA Neurol., 70, 1440, 10.1001/jamaneurol.2013.3090 Yang, 2011, Glut1 deficiency syndrome and erythrocyte glucose uptake assay, Ann Neurol., 70, 996, 10.1002/ana.22640 Pascual, 2002, Imaging the metabolic footprint of GLUT-1 deficiency on the brain, Ann Neurol., 52, 458, 10.1002/ana.10311 Von Moers, 2002, EEG features of glut-1 deficiency syndrome, Epilepsia., 43, 941, 10.1046/j.1528-1157.2002.50401.x Hully, 2015, From splitting GLUT1 deficiency syndromes to overlapping phenotypes, Eur J Med Genet., 58, 443, 10.1016/j.ejmg.2015.06.007 Liu, 2016, Evaluation of non-coding variation in GLUT1 deficiency, Dev Med Child Neurol., 58, 1295, 10.1111/dmcn.13163 Schoeler, 2015, Favourable response to ketogenic dietary therapies: undiagnosed glucose 1 transporter deficiency syndrome is only one factor, Dev Med Child Neurol., 57, 969, 10.1111/dmcn.12781 Keppler, 2015, GLUT deficiency syndrome and ketogenic diet therapies: missing rare but treatable diseases?, Dev Med Child Neurol, 57, 896, 10.1111/dmcn.12807 Garbern, 2010, A mutation affecting the sodium/proton exchanger SLC9A6, causes mental retardation with tau deposition, Brain., 133, 1391, 10.1093/brain/awq071 Kato, 2013, Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation, Epilepsia., 54, 1282, 10.1111/epi.12200 Johannesen, 2018, Defining the phenotypic spectrum of SLC6A1 mutations, Epilepsia., 59, 389, 10.1111/epi.13986 Lutas, 2016, The leak channel NALCN controls tonic firing and glycolytic sensitivity of substantia nigra pars reticulata neurons, Elife., 5, 1689, 10.7554/eLife.15271 Chong, 2015, De novo mutations in NALCN cause a syndrome characterized by congenital contractures of the limbs and face, hypotonia, and developmental delay, Am J Hum Genet., 96, 462, 10.1016/j.ajhg.2015.01.003 Krude, 2002, Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency, J Clin Invest., 109, 475, 10.1172/JCI0214341 Veggiotti, 2010, Glucose transporter type 1 deficiency: ketogenic diet in three patients with atypical phenotype, Brain Dev., 32, 404, 10.1016/j.braindev.2009.04.013